| 1 |
Cubitt_2020 |
A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity |
Cubitt, Beatrice; Ortiz-Riano, Emilio; Cheng, Benson YH.; Kim, Yu-Jin; Yeh, Charles D.; Chen, Catherine Z.; Southall, N.O.E.; Zheng, Wei; Martinez-Sobrido, Luis; de la Torre, Juan C. |
2020 |
2020-01-31 |
PMC |
N |
PMC6954049 |
31786250.0 |
10.1016/j.antiviral.2019.104667 |
ov5nmm1k |
0.587625 |
|
|
| 2 |
Tigabu_2014 |
A BSL-4 High-Throughput Screen Identifies Sulfonamide Inhibitors of Nipah Virus |
Tigabu, Bersabeh; Rasmussen, Lynn; White, E. Lucile; Tower, Nichole; Saeed, Mohammad; Bukreyev, Alexander; Rockx, Barry; LeDuc, James W.; Noah, James W. |
2014 |
2014-04-01 |
PMC |
N |
PMC3994909 |
24735442.0 |
10.1089/adt.2013.567 |
6vmam38y |
0.505367 |
|
|
| 3 |
Gowen_2011 |
Use of Recombinant Adenovirus Vectored Consensus IFN-α to Avert Severe Arenavirus Infection |
Gowen, Brian B.; Ennis, Jane; Russell, Andrew; Sefing, Eric J.; Wong, Min-Hui; Turner, Jeffrey |
2011 |
2011-10-24 |
COMM-USE |
N |
PMC3200317 |
22039436.0 |
10.1371/journal.pone.0026072 |
88wo4xen |
0.472655 |
|
|
| 4 |
Dallmeier_2016 |
Zika and Other Emerging Viruses: Aiming at the Right Target |
Dallmeier, Kai; Neyts, Johan |
2016 |
2016-10-12 |
PMC |
N |
|
27736642.0 |
10.1016/j.chom.2016.09.011 |
csni51kf |
0.437532 |
Klein_2009 |
|
| 5 |
Yu_Y_2020 |
Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection |
Yu, Yangsheng; Cooper, Christopher L.; Wang, Guangshun; Morwitzer, M. Jane; Kota, Krishna; Tran, Julie P.; Bradfute, Steven B.; Liu, Yan; Shao, Jiayu; Zhang, Amanda K.; Luo, Lindsey G.; Reid, St. Patrick; Hinrichs, Steven H.; Su, Kaihong |
2020 |
2020-04-24 |
None |
N |
PMC7104201 |
|
10.1016/j.isci.2020.100999 |
58abcben |
0.429757 |
|
Zhu_X_2015 |
| 6 |
Penny_2019 |
Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers |
Penny, Christopher J.; Vassileva, Kristin; Jha, Archana; Yuan, Yu; Chee, Xavier; Yates, Elizabeth; Mazzon, Michela; Kilpatrick, Bethan S.; Muallem, Shmuel; Marsh, Mark; Rahman, Taufiq; Patel, Sandip |
2019 |
2019-07-31 |
PMC |
N |
PMC7114365 |
30408544.0 |
10.1016/j.bbamcr.2018.10.022 |
40voizbv |
0.416876 |
|
Fan_H_2017, Chang_2019 |
| 7 |
Warren_2014 |
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430 |
Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Welch, Lisa S.; Minning, Dena M.; Babu, Yarlagadda S.; Sheridan, William P.; Bavari, Sina |
2014 |
2014-03-02 |
None |
N |
PMC7095208 |
24590073.0 |
10.1038/nature13027 |
uwdzic4k |
0.413901 |
|
|
| 8 |
Kumari_2020 |
A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors |
Nishi Kumari; Ayush Upadhyay; Kishan Kalia; Rakesh Kumar; Kanika Tuteja; Priyanka Rani Paul; Eugenia Covernton; Tina Sharma; Vinod Scaria; Anshu Bhardwaj |
2020 |
2020-03-12 |
BioRxiv |
N |
|
|
10.1101/2020.03.12.977918 |
o6v37h8w |
0.411163 |
|
Wu_H_2016 |
| 9 |
Salata_2019 |
Ebola Virus Entry: From Molecular Characterization to Drug Discovery |
Salata, Cristiano; Calistri, Arianna; Alvisi, Gualtiero; Celestino, Michele; Parolin, Cristina; Palù, Giorgio |
2019 |
2019-03-19 |
COMM-USE |
N |
PMC6466262 |
30893774.0 |
10.3390/v11030274 |
nfibuobt |
0.402618 |
|
|
| 10 |
Westover_2018 |
Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters |
Westover, Jonna B.; Mathis, Amanda; Taylor, Ray; Wandersee, Luci; Bailey, Kevin W.; Sefing, Eric J.; Hickerson, Brady T.; Jung, Kie-Hoon; Sheridan, William P.; Gowen, Brian B. |
2018 |
2018-08-31 |
PMC |
N |
|
29864447.0 |
10.1016/j.antiviral.2018.05.013 |
b9oenhez |
0.382053 |
|
|
| 11 |
DeWald_2019 |
In Vivo Activity of Amodiaquine against Ebola Virus Infection |
DeWald, Lisa Evans; Johnson, Joshua C.; Gerhardt, Dawn M.; Torzewski, Lisa M.; Postnikova, Elena; Honko, Anna N.; Janosko, Krisztina; Huzella, Louis; Dowling, William E.; Eakin, Ann E.; Osborn, Blaire L.; Gahagen, Janet; Tang, Liang; Green, Carol E.; Mirsalis, Jon C.; Holbrook, Michael R.; Jahrling, Peter B.; Dyall, Julie; Hensley, Lisa E. |
2019 |
2019-12-27 |
COMM-USE |
N |
PMC6934550 |
31882748.0 |
10.1038/s41598-019-56481-0 |
nuep8nim |
0.363086 |
Falzarano_2015, Dunning_2014, Wang_2016 |
Hsieh_2010, Wu_H_2016 |
| 12 |
Jochmans_2019 |
The path towards effective antivirals against rabies |
Jochmans, Dirk; Neyts, Johan |
2019 |
2019-08-02 |
PMC |
N |
|
29279280.0 |
10.1016/j.vaccine.2017.12.051 |
nk4zj3aa |
0.352342 |
Jerome_2005 |
|
| 13 |
Rasmussen_2015 |
Adapting High-Throughput Screening Methods and Assays for Biocontainment Laboratories |
Rasmussen, Lynn; Tigabu, Bersabeh; White, E. Lucile; Bostwick, Robert; Tower, Nichole; Bukreyev, Alexander; Rockx, Barry; LeDuc, James W.; Noah, James W. |
2015 |
2015-02-01 |
PMC |
N |
PMC4340648 |
25710545.0 |
10.1089/adt.2014.617 |
atjdufbg |
0.348618 |
Dove_2004 |
Trombetta_2018, Rasmussen_2011 |
| 14 |
Takayama-Ito_2020 |
Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection |
Takayama-Ito, Mutsuyo; Saijo, Masayuki |
2020 |
2020-02-11 |
COMM-USE |
N |
PMC7026129 |
32117168.0 |
10.3389/fmicb.2020.00150 |
0czu600e |
0.347495 |
|
|
| 15 |
Mathieu_2018 |
Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates |
Mathieu, Cyrille; Porotto, Matteo; Figueira, Tiago N; Horvat, Branka; Moscona, Anne |
2018 |
2018-03-16 |
PMC |
N |
PMC6009590 |
29566184.0 |
10.1093/infdis/jiy152 |
26pbzbxz |
0.344092 |
|
Hsieh_2010, Wu_H_2016 |
| 16 |
Agostini_2018 |
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease |
Agostini, Maria L.; Andres, Erica L.; Sims, Amy C.; Graham, Rachel L.; Sheahan, Timothy P.; Lu, Xiaotao; Smith, Everett Clinton; Case, James Brett; Feng, Joy Y.; Jordan, Robert; Ray, Adrian S.; Cihlar, Tomas; Siegel, Dustin; Mackman, Richard L.; Clarke, Michael O.; Baric, Ralph S.; Denison, Mark R. |
2018 |
2018-03-06 |
COMM-USE |
N |
PMC5844999 |
29511076.0 |
10.1128/mbio.00221-18 |
6dqy7tzc |
0.342122 |
|
|
| 17 |
de_la_Torre_2008 |
Reverse genetics approaches to combat pathogenic arenaviruses |
de la Torre, Juan C. |
2008 |
2008-12-31 |
None |
N |
PMC2628465 |
18782590.0 |
10.1016/j.antiviral.2008.08.002 |
wvtqbguq |
0.336412 |
|
|
| 18 |
Mirza_2019 |
Perspectives towards antiviral drug discovery against Ebola virus |
Mirza, Muhammad Usman; Vanmeert, Michiel; Ali, Amjad; Iman, Kanzal; Froeyen, Matheus; Idrees, Muhammad |
2019 |
2019-09-30 |
PMC |
N |
PMC7166701 |
30431654.0 |
10.1002/jmv.25357 |
zo1465i3 |
0.334268 |
Dove_2004 |
|
| 19 |
Warren_2016 |
Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys |
Warren, Travis K.; Jordan, Robert; Lo, Michael K.; Ray, Adrian S.; Mackman, Richard L.; Soloveva, Veronica; Siegel, Dustin; Perron, Michel; Bannister, Roy; Hui, Hon C.; Larson, Nate; Strickley, Robert; Wells, Jay; Stuthman, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Donnelly, Ginger; Shurtleff, Amy C.; Retterer, Cary J.; Gharaibeh, Dima; Zamani, Rouzbeh; Kenny, Tara; Eaton, Brett P.; Grimes, Elizabeth; Welch, Lisa S.; Gomba, Laura; Wilhelmsen, Catherine L.; Nichols, Donald K.; Nuss, Jonathan E.; Nagle, Elyse R.; Kugelman, Jeffrey R.; Palacios, Gustavo; Doerffler, Edward; Neville, Sean; Carra, Ernest; Clarke, Michael O.; Zhang, Lijun; Lew, Willard; Ross, Bruce; Wang, Queenie; Chun, Kwon; Wolfe, Lydia; Babusis, Darius; Park, Yeojin; Stray, Kirsten M.; Trancheva, Iva; Feng, Joy Y.; Baraskaus, Ona; Xu, Yili; Wong, Pamela; Braun, Molly R.; Flint, Mike; McMullan, Laura K.; Chen, Shan-Shan; Fearns, Rachel; Swaminathan, Swami; Mayers, Douglas L.; Spiropoulou, Christina F.; Lee, William A.; Nichol, Stuart T.; Cihlar, Tomas; Bavari, Sina |
2016 |
2016-03-02 |
None |
N |
PMC5551389 |
26934220.0 |
10.1038/nature17180 |
df3xig8r |
0.333819 |
|
|
| 20 |
Lai_K_2014 |
Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus |
Lai, Kang Yiu; Ng, Wing Yiu George; Cheng, Fan Fanny |
2014 |
2014-11-28 |
COMM-USE |
N |
PMC4334593 |
25699183.0 |
10.1186/2049-9957-3-43 |
f089bs8r |
0.329410 |
Dove_2004 |
|
| 21 |
Long_2015 |
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry |
Long, Jason; Wright, Edward; Molesti, Eleonora; Temperton, Nigel; Barclay, Wendy |
2015 |
2015-02-10 |
COMM-USE |
N |
PMC4431382 |
26069727.0 |
10.12688/f1000research.6085.2 |
57zy6unz |
0.312867 |
|
|
| 22 |
Arshad_2020 |
Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics |
Usman Arshad; Henry Pertinez; Helen Box; Lee Tatham; Rajith KR Rajoli; Paul Curley; Megan Neary; Joanne Sharp; Neill J Liptrott; Anthony Valentijn; Christopher David; Steve P Rannard; Paul O'Neill; Ghaith Aljayyoussi; Shaun Pennington; Stephen A Ward; David J Back; Saye H Khoo; Patrick G Bray; Giancarlo Biagini; Andrew Owen |
2020 |
2020-04-22 |
BioRxiv |
Y |
|
|
10.1101/2020.04.16.20068379 |
untuy1e6 |
0.306814 |
Ekins_2015 |
|